Skip to main content

Table 7 Interaction between FoxM1 expression and radiotherapy on HGG glioma survival

From: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma

FoxM1 expression

Radiotherapy

Patients

Deaths

MST(Months)

Adjusted HR (95% CI)

P*

High

Yes

143

133

4.7

1

 

High

No

413

298

9.7

5.486 (0.939-32.043)

0.05

Low

Yes

3

2

1.3

0.998 (1.91-5.217)

0.99

Low

No

8

6

3.8

0.76(0.41-14.072)

0.85

  1. *p-vale<0.05; Abbreviations: MST median survival time
  2. Adjusted for age, gender, race, and history neoadjuvant treatment